|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 4.120 USD | +1.23% |
|
+10.16% | +0.73% |
| 09-21 | Recursion Pharmaceuticals, Inc. Grants Tempus Ai, Inc. Non-Exclusive License for Rna Foundation Model | CI |
| 09-21 | Tempus AI, Recursion Extend Data License, Amend Fee Structure | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RXRX | Delayed | |
CBOE
| RXRX | Real-time | |
|
Mexican S.E.
| RXRX * | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bearish |
| Resistance | 4.13 | 4.13 | 4.2 |
| Spread/Res. | -0.24% | -0.24% | -1.90% |
| Spread/Supp. | +11.35% | +15.73% | +40.61% |
| Support | 3.7 | 3.56 | 2.93 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RXRX Stock
- Charts Recursion Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
